Pfizer · Stock-Based Compensation

Latest reported$947.00Mperiod endingJun 28, 2026

PFE Stock-Based Comp ($0.00 → $947.00M)

Annual stock-based compensation

High-resolution chart · PNG

PFE stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	799,000,000
Dec 31, 2024	877,000,000
Dec 31, 2023	525,000,000
Dec 31, 2022	872,000,000
Dec 31, 2021	1,182,000,000
Dec 31, 2020	756,000,000
Dec 31, 2019	718,000,000
Dec 31, 2018	949,000,000
Dec 31, 2017	840,000,000
Dec 31, 2016	691,000,000
Dec 31, 2015	669,000,000
Dec 31, 2014	586,000,000
Dec 31, 2013	523,000,000
Dec 31, 2012	481,000,000
Dec 31, 2011	419,000,000
Dec 31, 2010	405,000,000
Dec 31, 2009	349,000,000
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0